Clearmind Medicine Inc
clearmindmedicine.comWhat Do They Do?
Develops psychedelic drug candidates and an alcohol-substitute product for people with alcohol use disorder and other mental health conditions, including metabolic and eating disorders.
20-F for FY2025, filed Jan 20, 2026We are a clinical stage pharmaceutical company currently engaged in phase I/IIa clinical trials of novel psychedelic medicines to solve…View ↗
We are currently focusing our research programs on the uses of our proprietary, non-hallucinogenic, MEAI for the treatment of AUD, weight…View ↗
Our IP portfolio is composed of several neuroplastogen molecules and we successfully conducted research in several programs on different…View ↗
Who Do They Compete With?
Competes with Awakn Life Sciences, B.More, and Journey Colab
20-F for FY2025, filed Jan 20, 2026In the mental illnesses segments, we will face competition from psychedelic companies in general, and also from psychedelic companies that…View ↗
Loading...
